Work

Phase I/II Study of Gemcitabine and Exisulind as Second-Line Therapy in Patients with Advanced Non–small Cell Lung Cancer

Year: 2006

Type: article

Study design: Clinical Trial

Source: Journal of Thoracic Oncology

DOI: 10.1016/s1556-0864(15)31571-9

Authors: Tien Hoang, KyungMann Kim, Joseph Merchant, Anne M. Traynor, James McGovern, Kurt R. Oettel, Fredrico A. Sanchez, Harish G. Ahuja, Thomas A. Hensing, Martha Larson, Joan H. Schiller

Institutions: The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Eli Lilly and Company, National Cancer Institute

Awards: Clinical Academic Oncologist Training Program, G3472822613, G4151473777, G42679306

OpenAlex ID: W85952893

FWCI: 1.073

Cites: 43

Cited by: 8

Related to: 10